The U.S. Food and Drug Administration says drugmakers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.
New Jersey-based Teva Pharmaceuticals USA and drugs distributor Amerisource Health Services issued voluntary nationwide recalls earlier this month of more than 580,000 bottles of various strengths of prazosine capsules, according to the FDA.
-
![]()
New gummies are making your health easier -
![]()
B.C. study looks at teen vaping -
![]()
North Vancouver man with an ostomy running Squamish ultra-marathon -
![]()
Health Matters: World IVF Day -
![]()
Health Matters: When and how to use an Epipen -
![]()
Health Matters: Self-screening concussion tool for adolescents -
![]()
What wildfire smoke is really doing to your health -
![]()
Health Matters: Never Alone Campaign in support of men’s mental health -
![]()
Health Matters: Organ and tissue donation saves lives -
![]()
Health Matters: Alzheimer’s blood test
Doctors prescribe prazosin, which relaxes blood vessels, to help lower blood pressure. It also is sometimes prescribed for nightmares and other sleep disturbances caused by post-traumatic stress disorder.
Get weekly health news
The FDA said in enforcement orders posted online that it has given the affected lots of the drug a Class II risk classification because some of the recalled medication may have nitrosamine impurities that are considered potentially cancer causing.
According to the FDA, N-nitrosamine impurities are a class of potentially cancer-causing chemicals that can form during manufacture or storage of a drug.
Comments